Tonsillectomy

Oral sex is now the leading risk factor for throat cancer

Retrieved on: 
Tuesday, April 25, 2023
Infection, Oropharyngeal cancer, DNA, Tonsillectomy, Travel, Vaccination, Coronavirus, Policy, Cancer, Partner (business rank), Human papillomavirus infection, School, Cervical cancer, Patient, Time, Immune system, HPV, Ageing, Otorhinolaryngology, Mouth, Safety, Birth control, Vaccine

This has been due to a large rise in a specific type of throat cancer called oropharyngeal cancer (the area of the tonsils and back of the throat).

Key Points: 
  • This has been due to a large rise in a specific type of throat cancer called oropharyngeal cancer (the area of the tonsils and back of the throat).
  • Oropharyngeal cancer has now become more common than cervical cancer in the US and the UK.
  • For oropharyngeal cancer, the main risk factor is the number of lifetime sexual partners, especially oral sex.
  • Those with six or more lifetime oral-sex partners are 8.5 times more likely to develop oropharyngeal cancer than those who do not practise oral sex.

Masimo Opioid Halo™ Granted De Novo for the First and Only FDA-Authorized Opioid Overdose Prevention and Alert System

Retrieved on: 
Monday, April 3, 2023
Software, Mobile, Wireless, Pharmaceutical, Telemedicine, Virtual Medicine, Consumer Electronics, Consumer, Mental Health, Apps, Applications, Technology, Medical Devices, Other Consumer, FDA, Health, CHC, Intermountain Health, Tonsillectomy, De novo, Friends, Naloxone, LAUNCH (Innovation Challenge), RRT, Parent, COVID-19, Opioid use disorder, Opioid overdose, Prescription, Physiology, Multimedia, COVID, Heroin, Movement, Pain, EMS, Drug-related deaths in the United Kingdom, MASI, Patient, De novo gene birth, Risk, OTC, Research, Death, Fentanyl, Family, Caregiver, Cereal, Nursing, Masimo

Masimo (NASDAQ: MASI) today announced that Masimo Opioid Halo™ , an opioid overdose prevention and alert system, has been granted a De Novo by the FDA – making it the first and only FDA-cleared monitoring solution for detecting opioid-induced respiratory depression, the leading cause of death from opioid overdose.

Key Points: 
  • Masimo (NASDAQ: MASI) today announced that Masimo Opioid Halo™ , an opioid overdose prevention and alert system, has been granted a De Novo by the FDA – making it the first and only FDA-cleared monitoring solution for detecting opioid-induced respiratory depression, the leading cause of death from opioid overdose.
  • With the De Novo, Masimo also becomes the first winner of an FDA Opioid Innovation Challenge to have an authorized solution designed to help solve the U.S. opioid crisis.
  • Opioid Halo advances the forefront of continuous monitoring through its unique Opioid Halo engine, an advanced pattern recognition algorithm which helps detect and quantify the risk of severe opioid-induced respiratory depression.
  • And today, we are delighted to have received the first De Novo for our response to that Innovation Challenge, Masimo Opioid Halo.

New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques

Retrieved on: 
Thursday, March 23, 2023
Contraindication, Sleep apnea, American Academy of Otolaryngology–Head and Neck Surgery, LSE, Tonsillectomy, Surgeon, Diet, Use, Directory of Open Access Journals, Open access, CIT, American Academy, Research, Temperature, Meta-analysis, PTH, Blood, Otorhinolaryngology, Pain, Literature, Patient, SNN, NYSE, Pharmaceutical industry

COBLATION Intracapsular Tonsillectomy involves the removal of all, or the majority, of tonsil tissue while maintaining the integrity of the underlying capsule.

Key Points: 
  • COBLATION Intracapsular Tonsillectomy involves the removal of all, or the majority, of tonsil tissue while maintaining the integrity of the underlying capsule.
  • Intracapsular Tonsillectomy is growing in popularity with 20% of paediatric otolaryngologists performing this procedure in the US.2
    For more information about COBLATION Intracapsular Tonsillectomy, please visit https://www.smith-nephew.com/en/health-care-professionals/products/ear-n...
    1.
  • Sedgwick MJ, Saunders C, Bateman N. Intracapsular tonsillectomy using plasma ablation versus total tonsillectomy: a systematic literature review and meta-analysis.
  • Post Tonsillectomy Haemorrhage (PTH) is a potentially serious complication that has been reported in literature for both adult and paediatric patients.

New evidence demonstrates Smith+Nephew's COBLATION™ Technology can accelerate patient recovery with fewer complications compared with total tonsillectomy techniques

Retrieved on: 
Thursday, March 23, 2023
Contraindication, Sleep apnea, American Academy of Otolaryngology–Head and Neck Surgery, LSE, Tonsillectomy, Surgeon, Diet, Use, Directory of Open Access Journals, Open access, CIT, American Academy, Research, Temperature, Meta-analysis, PTH, Blood, Otorhinolaryngology, Pain, Literature, Patient, SNN, NYSE, Pharmaceutical industry

COBLATION Intracapsular Tonsillectomy involves the removal of all, or the majority, of tonsil tissue while maintaining the integrity of the underlying capsule.

Key Points: 
  • COBLATION Intracapsular Tonsillectomy involves the removal of all, or the majority, of tonsil tissue while maintaining the integrity of the underlying capsule.
  • Intracapsular Tonsillectomy is growing in popularity with 20% of paediatric otolaryngologists performing this procedure in the US.2
    For more information about COBLATION Intracapsular Tonsillectomy, please visit https://www.smith-nephew.com/en/health-care-professionals/products/ear-n...
    1.
  • Sedgwick MJ, Saunders C, Bateman N. Intracapsular tonsillectomy using plasma ablation versus total tonsillectomy: a systematic literature review and meta-analysis.
  • Post Tonsillectomy Haemorrhage (PTH) is a potentially serious complication that has been reported in literature for both adult and paediatric patients.

Ayal Willner, MD, is recognized by Continental Who's Who

Retrieved on: 
Friday, January 27, 2023
Multimedia, MD, Miller Children's Hospital, Head, Education, ENT, Mending Kids International, Cornell University, American Board of Commissioners for Foreign Missions, Private practice, Continental, George Washington University, Hospital, Le Bonheur Children's Hospital, American Academy, Castle Connolly Medical, Interventional cardiology, Otorhinolaryngology, American Academy of Otolaryngology–Head and Neck Surgery, Long Beach Memorial Medical Center, Albert Einstein College of Medicine, Tonsillectomy, National Institute of Ear, Nose and Throat, Bangladesh, Society, Pediatrics (journal), American College, Assistant, Dentistry, Biology, Pediatrics, Child

Dr. Ayal Willner began his college education at Cornell University, graduating with a Bachelor of Science degree in Biology.

Key Points: 
  • Dr. Ayal Willner began his college education at Cornell University, graduating with a Bachelor of Science degree in Biology.
  • He is board-certified by the American Board of Otolaryngology - Head & Neck Surgery and has been in the medical profession for over 30 years.
  • Dr. Willner is a Pediatric Otolaryngologist specialist with a private practice called Southern California Ear Nose and Throat (SCENT).
  • Dr. Willner treats children and adults, addressing a wide range of issues and performing complex ear, sinus, and skull surgeries.

ENT Care Centers Advances Ear, Nose, and Throat Care In the Louisville Region By Uniting Quality Providers Under One Trusted Name

Retrieved on: 
Tuesday, December 13, 2022
Audiology, Community, Tonsillectomy, Health, Patient, Human skull symbolism, Nose, Otorhinolaryngology, Kool-Aid, Sleep apnea, Adenoidectomy, Ear, PLLC, Hearing, ENT, Hospital, Dentistry, Greater Louisville Inc.

LOUISVILLE, Ky., Dec. 13, 2022 /PRNewswire-PRWeb/ -- ENT Care Centers, PLLC is leading the way for quality ear, nose, and throat care in the Louisville area with its collaborative approach to industry innovation and patient care. The newly formed medical practice aggregation combines four of the Louisville area's top otolaryngologic providers Kentuckiana ENT, ENT Associates, Community ENT, and Louisville ENT under one umbrella and mission, all committed to offering a better continuum of care and enhancing patient outcomes.

Key Points: 
  • LOUISVILLE, Ky., Dec. 13, 2022 /PRNewswire-PRWeb/ -- ENT Care Centers, PLLC is leading the way for quality ear, nose, and throat care in the Louisville area with its collaborative approach to industry innovation and patient care.
  • "ENT Care Centers is proud to serve as a hub for medical innovation and the gold standard for otolaryngologic care throughout the Louisville area and Southern Indiana," said Dr. Thomas Higgins, ENT Care Centers president and chairman of the board.
  • To learn more about ENT Care Centers and its locations across the Greater Louisville region and Southern Indiana, visit https://www.entcarecenters.com/.
  • ENT Care Centers is the collaborative effort of four ENT practices in Louisville, KY and Jeffersonville, INKentuckiana ENT, Louisville Family ENT, Community ENT, and ENT Associates.

Ayal Willner, MD is recognized by Continental Who's Who

Retrieved on: 
Monday, November 28, 2022
American Academy of Otolaryngology–Head and Neck Surgery, Tonsillectomy, Head, Otorhinolaryngology, Hospital, American College, ENT, Sleep apnea, Multimedia, Le Bonheur Children's Hospital, Long Beach Memorial Medical Center, George Washington University, Education, Society, Miller Children's Hospital, MD, Cornell University, American Board of Commissioners for Foreign Missions, Fellowship of the Royal Colleges of Surgeons, Assistant, Private practice, Mending Kids International, Albert Einstein College of Medicine, American Academy, National Institute of Ear, Nose and Throat (ENT), Bangladesh, Interventional cardiology, Continental, Pediatrics (journal), Medicine, Dentistry, Pediatrics, Child, Biology

LONG BEACH, Calif., Nov. 28, 2022 /PRNewswire/ -- Ayal Willner, MD, is being recognized by Continental Who's Who as a Distinguished Otolaryngologist, Partner, and Owner in the medical field and in acknowledgment of his professional excellence at Southern California Ear Nose and Throat (SCENT).

Key Points: 
  • LONG BEACH, Calif., Nov. 28, 2022 /PRNewswire/ -- Ayal Willner, MD, is being recognized by Continental Who's Who as a Distinguished Otolaryngologist, Partner, and Owner in the medical field and in acknowledgment of his professional excellence at Southern California Ear Nose and Throat (SCENT).
  • Dr. Willner is a Pediatric Otolaryngologist specialist with his own private practice called Southern California Ear Nose and Throat (SCENT).
  • Dr. Ayal Willner began his college education at Cornell University, graduating with a Bachelor of Science degree in Biology.
  • He later received his medical degree and completed an Otolaryngology residency at the Albert Einstein College of Medicine.

Nasal Cleansing System Shows Potential for Increasing Compliance in CPAP Patients

Retrieved on: 
Thursday, November 3, 2022
CPAP, Bacteria, Obstructive sleep apnea, OSA, Congress, Compliance, Methicillin-resistant Staphylococcus aureus, Stroke, Research, Technology, Cardiovascular disease, MD, Hypertension, Patient, Nose, Death, CCENT, Diabetes, FARS, Sleep, American College, ENT, Tonsillectomy, MRSA, Mask, Multimedia, Sleep apnea, Pharmaceutical industry, Medical device

FRISCO, Texas, Nov. 3, 2022 /PRNewswire/ -- A novel nasal cleansing system (NasoClenzTM, Silicon Valley Innovations, Sunnyvale, CA) reduced bacterial colonization while increasing comfort and compliance in patients that use continuous positive airway pressure (CPAP) to treat sleep apnea, according to results of a clinical evaluation recently presented at the American College of Surgeons Clinical Congress.

Key Points: 
  • "Sleep apnea is a very serious health issue," said lead author and presenter Keith Matheny, MD, FARS, "anything we can offer patients that might help improve compliance with CPAP will have a tremendous impact on patients' lives."
  • Decades of research have found that using CPAP during sleep has significant benefits for these patients; however, long term compliance is very low due to discomfort with the masks and the extreme nasal dryness the airflow causes.
  • Participating patients used the pre-packaged NasoClenz kits before and after using CPAP for a period of two weeks.
  • Patients were very positive in their overall response, with 82% of them reporting that NasoClenz is beneficial for routine use with CPAP.

New Study from StrategyR Highlights a $3.7 Billion Global Market for Ultrasonic Scalpels by 2026

Retrieved on: 
Wednesday, March 23, 2022
Adoption, Ultrasound, CAGR, Appendectomy, Tonsillectomy, Players, ENT, Investment, Marketing, Growth, Urology, Uterine fibroid, General surgery, Research, Culdocentesis, Forecasting, Thyroidectomy, Bleeding, Tissue, Intelligence, Stryker Corporation, Prevalence, Joint, Gynaecology, Surgeon, GIA, COVID-19, Olympus Corporation, Endometriosis, Attention, VDW, Spine, SAN, Medtronic, Scalpel, Pain, Johnson & Johnson, Pharmaceutical industry, Others

SAN FRANCISCO, March 23, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Ultrasonic Scalpels - Global Market Trajectory & Analytics" .

Key Points: 
  • SAN FRANCISCO, March 23, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Ultrasonic Scalpels - Global Market Trajectory & Analytics" .
  • Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more.
  • This segment currently accounts for a 29.8% share of the global Ultrasonic Scalpels market.
  • Global Industry Analysts, Inc., ( www.strategyr.com ) is a renowned market research publisher the world`s only influencer driven market research company.

Wayne J. Harsha, MD, is recognized by Continental Who's Who

Retrieved on: 
Tuesday, March 8, 2022
Neck, National Institute of Ear, Nose and Throat (ENT), Bangladesh, Hearing loss, Medical Park, Mayo Clinic, Patient, American Board of Otolaryngology, Medicine, Rhinoplasty, Society, Health, Fellow, United States Army, Tonsillectomy, Hiram, Medical college, Army of the United States, Solution, ENT, Mentorship, Multimedia, Head, Cancer, Allergy, Microvascular decompression, Newberry County Memorial Hospital, Youth ministry, Parent, Education, American Board of Commissioners for Foreign Missions, Malignancy, Master, ROTC, Madigan Army Medical Center, Furman University, Clinical professor, Dentistry, Chemistry, Otorhinolaryngology, MD, Christian apologetics

Dr. Harsha founded his ENT practice after previously providing medical care in Washington and Arizona for 19 years.

Key Points: 
  • Dr. Harsha founded his ENT practice after previously providing medical care in Washington and Arizona for 19 years.
  • At Carolina Pines ENT, Dr. Harsha provides patients with a full range of Ear Nose and Throat care options.
  • He performs allergy testing, cosmetic procedures, esthetic procedures, and head and neck tumor treatment for both malignant and benign tumors.
  • In 2020, he opened the solo practice in his hometown Newberry, SC, at 2032 Medical Park Dr.